Your browser doesn't support javascript.
loading
Immunity to Cryptosporidium: Lessons from Acquired and Primary Immunodeficiencies.
Cohn, Ian S; Henrickson, Sarah E; Striepen, Boris; Hunter, Christopher A.
Affiliation
  • Cohn IS; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA.
  • Henrickson SE; Institute for Immunology, University of Pennsylvania, Philadelphia, PA; and.
  • Striepen B; Division of Allergy Immunology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA.
  • Hunter CA; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA.
J Immunol ; 209(12): 2261-2268, 2022 12 15.
Article in En | MEDLINE | ID: mdl-36469846
Cryptosporidium is a ubiquitous protozoan parasite that infects gut epithelial cells and causes self-limited diarrhea in immunocompetent individuals. However, in immunocompromised hosts with global defects in T cell function, this infection can result in chronic, life-threatening disease. In addition, there is a subset of individuals with primary immunodeficiencies associated with increased risk for life-threatening cryptosporidiosis. These patients highlight MHC class II expression, CD40-CD40L interactions, NF-κB signaling, and IL-21 as key host factors required for resistance to this enteric pathogen. Understanding which immune deficiencies do (or do not) lead to increased risk for severe Cryptosporidium may reveal mechanisms of parasite restriction and aid in the identification of novel strategies to manage this common pathogen in immunocompetent and deficient hosts.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cryptosporidiosis / Cryptosporidium / Immunologic Deficiency Syndromes Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Immunol Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cryptosporidiosis / Cryptosporidium / Immunologic Deficiency Syndromes Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Immunol Year: 2022 Document type: Article Country of publication: